Nautilus Biotechnolgy, Inc. Common Stock (NAUT) Stock Price, Quote & AI Analysis
Live NAUT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Nautilus Biotechnolgy, Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Nautilus Biotechnolgy, Inc. Common Stock (NAUT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Nautilus Biotechnolgy, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Nautilus Biotechnolgy, Inc. Common Stock Overview
Company information
Company Overview
Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Nautilus Biotechnolgy, Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...